We are live on ! Find out more
SG

StoneX Group Portfolio holdings

AUM $1.86B
1-Year Est. Return 21.3%
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
+21.3%
3 Year Est. Return
+67.54%
5 Year Est. Return
+78.7%
10 Year Est. Return
AUM
$687M
AUM Growth
+$150M
Cap. Flow
+$115M
Cap. Flow %
16.76%
Top 10 Hldgs %
38.7%
Holding
678
New
317
Increased
139
Reduced
121
Closed
86

Sector Composition

Rank Sector Weight
1 Healthcare 1.9%
2 Industrials 1.84%
3 Financials 1.61%
4 Energy 1.31%
5 Technology 1.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WPRT
451
Westport Fuel Systems
WPRT
$36.5M
$9.55K ﹤0.01%
+1,232
New +$10.6K
ADXN
452
Addex Therapeutics
ADXN
$9.45K ﹤0.01%
+750
New +$11.1K
DHC
453
Diversified Healthcare Trust
DHC
$2.26B
$9.38K ﹤0.01%
+14,496
New +$14.3K
GETR
454
DELISTED
Getaround, Inc.
GETR
$9.26K ﹤0.01%
+14,188
New +$109K
KLR
455
DELISTED
Kaleyra, Inc.
KLR
$9.23K ﹤0.01%
+3,493
New +$11.6K
CTXR icon
456
Citius Pharmaceuticals
CTXR
$14.3M
$8.77K ﹤0.01%
+444
New +$12.1K
BTBT icon
457
Bit Digital
BTBT
$484M
$8.66K ﹤0.01%
+14,433
New +$13.5K
HOOK
458
DELISTED
HOOKIPA Pharma
HOOK
$8.62K ﹤0.01%
+1,064
New +$11.5K
TRAW icon
459
Traws Pharma
TRAW
$7.43M
$8.44K ﹤0.01%
523
-77
-13% -$1.45K
TIO
460
DELISTED
Tingo Group, Inc. Common Stock
TIO
$8.34K ﹤0.01%
+10,045
New +$8.45K
PUCKW
461
DELISTED
Goal Acquisitions Corp. Warrant
PUCKW
$8.24K ﹤0.01%
+177,300
New +$8.46K
EBET
462
DELISTED
EBET, INC. Common Stock
EBET
$8.17K ﹤0.01%
432
-48
-10% -$1.11K
AQB icon
463
AquaBounty Technologies
AQB
$4.68M
$8.13K ﹤0.01%
+532
New +$7.24K
CLIR icon
464
ClearSign Technologies
CLIR
$22M
$8.04K ﹤0.01%
+1,500
New +$10.5K
BGRY
465
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
$7.94K ﹤0.01%
+13,142
New +$14.7K
CARM
466
DELISTED
Carisma Therapeutics
CARM
$7.92K ﹤0.01%
+650
New +$6.83K
LOGC
467
DELISTED
ContextLogic
LOGC
$7.8K ﹤0.01%
+533
New +$11K
LTRPA
468
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$7.64K ﹤0.01%
+11,405
New +$10.7K
SRXH
469
SRX Global
SRXH
$35.1M
$7.55K ﹤0.01%
+7
New +$11.5K
DRUG
470
Bright Minds Biosciences
DRUG
$700M
$7.54K ﹤0.01%
+2,039
New +$10.1K
GOVX icon
471
GeoVax Labs
GOVX
$3.81M
$7.39K ﹤0.01%
+31
New +$9.41K
BODI icon
472
The Beachbody Company
BODI
$78.9M
$7.25K ﹤0.01%
+276
New +$12K
VRPX
473
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
$7.22K ﹤0.01%
+46
New +$10.5K
MLSS icon
474
Milestone Scientific
MLSS
$34.5M
$7.2K ﹤0.01%
15,000
CFIVW
475
DELISTED
CF Acquisition Corp. IV Warrant
CFIVW
$7.12K ﹤0.01%
92,520
-60,900
-40% -$2.91K

Similar funds

StoneX Group's Q4 2022 Portfolio in Review

As of Q4 2022, StoneX Group held 678 positions worth $687M, up 28% from $537M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

StoneX Group deployed $115M of net new capital in Q4 2022, opening 317 new positions and adding to 139 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 7,758 shares worth $2.98M.

By sector, the portfolio is most concentrated in Healthcare at 1.9% of assets, up from 0.03% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Vanguard Mega Cap Growth ETF, an estimated $4.64M trimmed.

  • StoneX Group's largest Q4 2022 buy was State Street SPDR S&P 500 ETF Trust: 7,758 shares worth $2.98M.
  • StoneX Group added most to iShares Russell Mid-Cap ETF in Q4 2022, an estimated $12.3M increase.
  • StoneX Group's biggest Q4 2022 reduction was Vanguard Mega Cap Growth ETF, cutting an estimated $4.64M.
  • StoneX Group fully exited Lefteris Acquisition Corp. Class A Common Stock in Q4 2022, selling an estimated $2.17M.
  • StoneX Group's ten largest holdings make up 39% of its $687M portfolio in Q4 2022.
  • StoneX Group opened 317 new positions and closed 86 in Q4 2022.
  • StoneX Group's portfolio value rose 28% quarter-over-quarter to $687M.

Based on StoneX Group's 13F filing for Q4 2022, filed 10 Feb 2023.